Aortic remodelling induced by obstructive apneas is normalized with mesenchymal stem cells infusion by Rubies, Cira et al.
1Scientific RepoRtS |         (2019) 9:11443  | https://doi.org/10.1038/s41598-019-47813-1
www.nature.com/scientificreports
Aortic remodelling induced by 
obstructive apneas is normalized 
with mesenchymal stem cells 
infusion
cira Rubies1, Ana-paula Dantas1, Montserrat Batlle1,2, Marta torres3,5, Ramon farre1,4,5, 
Gemma Sangüesa1,2, Josep M. Montserrat1,3,5, Lluis Mont1,2,6, isaac Almendros  1,4,5 & 
eduard Guasch  1,2,6
Obstructive sleep apnea syndrome (OSA) promotes aortic dilatation, increased stiffness and accelerated 
atherosclerosis, but the mechanisms of vascular remodelling are not known. We aimed to assess 
vascular remodelling, its mechanisms, and the effect of mesenchymal stem cells (MSC) infusions in a 
clinically relevant rat model of chronic oSA involving recurrent airway obstructions leading thoracic 
pressure swings and intermittent hypoxia/hypercapnia (oSA-rats). Another group of rats were placed 
in the same setup without air obstructions (Sham-rats) and were considered controls. our study 
demonstrates that chronic, non-invasive repetitive airway obstructions mimicking oSA promote 
remarkable structural changes of the descending thoracic aorta such as eccentric aortic hypertrophy 
due to an increased wall thickness and lumen diameter, an increase in the number of elastin fibers 
which, in contrast, get ruptured, but no changes in tunica media fibrosis. As putative molecular 
mechanisms of the OSA-induced vascular changes we identified an increase in reactive oxygen species 
and renin-angiotensin system markers and an imbalance in oxide nitric synthesis. our results also 
indicate that MSc infusion blunts the oSA-related vascular changes, most probably due to their anti-
inflammatory properties.
Obstructive sleep apnea syndrome (OSA) is a common sleep-related breathing disorder characterized by recur-
rent episodes of partial or complete obstruction of the upper airway. Numerous studies have identified severe 
OSA as a risk factor for hypertension, heart failure, stroke, and mortality1. Moreover, growing evidence suggests 
that untreated OSA accelerates atherosclerosis2, which may mediate the increased cardiovascular disease burden 
in OSA patients. Several mechanisms linking OSA with vascular complications have been postulated, including 
intermittent hypoxia (IH) and hypercapnia, intrathoracic swings, repeated arousals, and sympathetic system acti-
vation, all them potentially acting via inflammation, endothelial dysfunction, and oxidative stress3.
In these patients, comorbidities such as obesity, diabetes and hypertension often coexist with, or are induced 
by, OSA, and hamper establishing an independent association between OSA and the progression of atherosclero-
sis. The use of animal models overcomes the confounding effects of comorbidities and enables the exploration of 
the pathophysiological consequences of OSA. The most widely used animal model of sleep apnea selectively reca-
pitulates IH4–6. Although IH is an important characteristic of OSA, this model is limited by the absence of recur-
rent upper airway obstructions and consequent deep intrathoracic pressure swings. Some alternative models need 
of an invasive approach to induce airway obstruction, limiting the exploration of the long-term consequences of 
OSA7,8. However, our group has developed a setup that non-invasively reproduces recurrent airway obstructions9, 
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resulting in increased breathing efforts, oxygen desaturations and intermittent hypercapnia mimicking severe 
OSA (apnea-hypopnea-index [AHI] > 30 per hour).
Eventually, a systemic pro-inflammatory environment10 that locally extends to the cardiovascular system11,12 
seems to be a major contributor to OSA-related deleterious cardiovascular outcomes. In this setting, bone marrow 
mesenchymal stem cells (MSC) appear a promising therapeutic approach because of their anti-inflammatory13 
and anti-fibrotic12,14 effects. Of note, MSC are mobilized into circulating blood early in the course of OSA15. The 
putative therapeutic effect of MSC on atrial fibrosis and systemic inflammation has been previously demonstrated 
in our OSA rat model12,13.
Our objectives in the present study were (a) to assess vascular remodelling after long-term repetitive obstruc-
tive apneas in a clinically relevant rat model, (b) to study its mechanisms, and (c) to test the effects of MSC infu-
sion in the progression of OSA-induced deleterious vascular remodelling.
Results
Morphological vascular remodelling induced by oSA. Recurrent apneas prompted evident changes 
in descending aorta morphology and structure. A representative microphotograph is shown in Fig. 1a. The aortic 
wall thickness (WT, Fig. 1b) and lumen diameter (Fig. 1c) were significantly increased in OSA compared with 
Sham rats. Overall, WT thickening prevailed, as denoted by a higher WT to lumen ratio (WT/L, Fig. 1d) in OSA 
rats.
We subsequently studied elastic fiber organization in the descending thoracic aorta (Fig. 1e). Our analyses 
demonstrated a significant increase of elastic fiber ruptures in OSA rats compared to Sham rats (Fig. 1f). OSA rats 
had more elastic fibers in the aorta than Sham rats (Fig. 1g).
Tunica media fibrosis in the aorta was assessed by means of Picrosirius red staining. Quantification of colla-
gen deposition did not show differences between Sham and OSA groups (Fig. 2a,b). Collagen subtype analysis 
with polarized light (Fig. 2c) demonstrated similar deposition of each collagen I and III (Fig. 2d,e, respectively) 
between groups.
To assess the morphological remodelling of muscular arteries, we analysed the lumen, tunica media and 
perivascular areas of both left and right ventricle mid-ventricular intramyocardial arteries (Fig. 3a). We did not 
find any changes in the relative size of the tunica media nor of the lumen, nor in the amount of perivascular fibro-
sis in muscular arteries from OSA rats compared with sham. The lack of changes was consistent across the right 
(Fig. 3b) and the left ventricle (Fig. 3c).
Mechanisms of oSA-induced vascular remodelling. Oxidative stress and both nitric oxide and 
renin-angiotensin pathways were explored as potential contributors to vascular remodelling in OSA. Superoxide 
production in the aortic tunica media was estimated with dihydroethidium (DHE) fluorescence (Fig. 4a). 
Analyses demonstrated increased DHE fluorescence in the OSA compared to the Sham group (Fig. 4b). Protein 
levels of the NADPH oxidase subunit p47-phox were higher in aortas from OSA compared to Sham rats 
(Fig. 4c,d).
Figure 1. Aortic morphological remodelling induced by OSA. Representative haematoxylin-eosin stained 
aortic sections from Sham and OSA rats (a). Column graph of aortic wall thickness (µm, b), lumen diameter 
(mm, c), wall thickness to lumen ratio (%, d) from Sham (n = 11, white columns) and OSA (n = 12, blue 
columns) rats. Representative elastin auto fluorescence images from aorta wall from Sham and OSA rats (e). 
White arrow in the picture from an OSA rat shows an elastic fiber rupture. Number of fiber ruptures indexed 
per area (Fiber ruptures/mm2, f) and number of elastic fibers relative to aorta section (g) in Sham (n = 12, white 
columns) and OSA (n = 16, blue columns) rats. Data are expressed as mean ± SEM, *p < 0.05, **p < 0.01.
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Enzymes involved in nitric oxide were also quantified. The OSA group showed decreased eNOS protein 
(Fig. 5a,b) levels compared to the Sham group, while reduction in eNOS mRNA expression was not significant, 
suggesting post-transcriptional regulation mechanisms (Fig. 5d). Messenger RNA levels of iNOS were similar 
between groups (Fig. 5e). Elevated ACE1 protein levels in OSA rats suggested renin-angiotensin-aldosterone 
system enhancement (Fig. 5a,c).
Mesenchymal Stem cell infusions blunt oSA-induced vascular changes. To analyse the effect of 
mesenchymal stem cell (MSC) infusions in OSA-induced aortic structural remodelling, morphological parame-
ters were studied in aortic sections from Sham rats infused with saline vehicle (Sham + S) and rats subjected to the 
airway obstructions and MSC infusions (OSA + M). MSC infusion reverted most OSA-induced aortic structural 
changes. No differences in WT (Fig. 6a,b), lumen diameter (Fig. 6a,c), and the WT/L (Fig. 6a,d) were observed 
between groups. Also, the number of elastic fiber ruptures per area was not statistically different between aortas 
from Sham + S and OSA + M rats (Fig. 6e,f). Nevertheless, the number of elastic fibers per section remained 
elevated in OSA + M group (Fig. 6e,g).
Increased aortic superoxide generation by OSA was prevented by the administration of MSC, yielding similar 
levels of intranuclear DHE fluorescence in both Sham + S and OSA + M rats (Fig. 7a). Similarly, eNOS pro-
tein (Fig. 7b) and mRNA levels (Fig. 7d) were similar between groups after MSC administration. Conversely, 
MSC infusion dramatically decreased iNOS mRNA expression (Fig. 7e). ACE1 protein levels were comparable in 
Sham + S and OSA + M rats (Fig. 7c).
Discussion
This study demonstrates for the first time that chronic, non-invasive repetitive airway obstructions mimicking 
OSA promote remarkable structural changes of the descending thoracic aorta as well as an increase in reactive 
oxygen species (ROS), endothelial dysfunction and renin-angiotensin system (RAS) markers. Our results also 
indicate that MSC infusion blunts OSA-related vascular changes.
We demonstrate that OSA-induced aortic structural remodelling is characterized by lumen dilatation and 
hypertrophy of the vessel wall, an increased number of elastic fibers, and a higher number of fiber ruptures. In 
accordance with our results, exposure to IH has been shown to induce an expansive aortic remodelling with 
intima-media thickening (IMT) in 14-day16 and 6-week17 mice models. In these models, increased elastic fiber 
disorganization and fragmentation accompanied wall thickening. Also, an increase of tunica media thickness 
along with elastic fibers ruptures and disorganization have been demonstrated in a canine invasive OSA model 
of 12 weeks of duration18. Perturbations in the continuity of elastic lamina with disruption of the elastic fibers 
are apparent during early stages of atherogenesis in apoE knockout (apoE−/−) mice and may act as a potential 
substrate for subsequent development of aortic lesions19.
The realistic animal model used in this work mimics recurrent obstructive apneas observed in OSA patients. 
The animals were subjected to both intermittent hypoxia-reoxygenation events, like in IH models, and negative 
Figure 2. Aortic collagen content. Representative picrosirius-stained aortic OCT sections of Sham and OSA 
rats (a) and column graph of the quantification of percentage of collagen deposition (b) of Sham (n = 11, white 
columns) and OSA rats (n = 15, blue columns). Representative picrosirius-stained aortic OCT sections obtained 
under polarized light are shown in (c). Column graphs of collagen I (d) and collagen III (e) quantification of 
Sham (n = 7, white columns) and OSA rats (n = 8, blue columns).Data are expressed as mean ± SEM.
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intrathoracic pressure swings associated with strenuous breathing efforts. We have previously shown that this 
model results in an arterial oxygen saturation (SaO2) fall to ≈80% associated with intermittent hypercapnia9. 
We hypothesize that the OSA-related increased lumen diameter in our work may be linked to the intrathoracic 
pressure swings observed in OSA. Those pressure swings cause shear and wall stress in intrathoracic blood ves-
sels20, altering its mechanical properties and ultimately resulting in aortic dilatation21. In addition to the increased 
intrathoracic pressure swings, the airway obstructions in our OSA model mimicked the intermittent hypercapnia 
events as experienced in patients. In this context, it has been recently suggested that the combination of hypoxia 
with hypercapnia in apoE and low density lipoprotein receptor Ldlr-deficient mice might accelerate the progres-
sion of atherosclerosis in the aorta and in the pulmonary artery22.
The lack of neither a collagen increase nor shift in collagen I and III percentage in the aortas of our 21-day 
OSA model, together with the results from the literature, suggests that collagen deposition is a late event of vas-
cular remodelling triggered by repeated hypoxia episodes. No changes in collagen content were reported after 14 
days of IH exposure16, while an extension of the IH time exposure up to 6 weeks17,23 or an invasive OSA model up 
to 12 weeks18 led to an elevated accumulation of collagen fibers in the aortas.
In our study we did not find changes in tunica media thickness or perivascular fibrosis in muscular intramy-
ocardial vessels. Again, results from the 6 weeks exposure to IH reveal higher perivascular fibrosis in intramyo-
cardial vessels17,23 indicating that collagen deposition in those vessels could be related to a longer IH exposure.
In human studies, patients with OSA display signs of vascular remodelling, including increased carotid IMT 
and increased arterial stiffness compared to control subjects2,24. Nevertheless, the association between OSA and 
the ascending aorta diameter in humans remains controversial. Most studies reported a positive association 
between the aorta diameter and parameters of OSA severity21,25,26 although conflicting data has also been pub-
lished27,28, likely because of heterogeneity in study designs and cohort composition.
Figure 3. Intramyocardial vessels remodelling. Representative picrosirius-stained pictures of intramyocardial 
arteries of Sham and OSA rats (a). Percentage (%) of tunica media area relative to vessel size, percentage of 
lumen area relative to vessel size, and percentage of perivascular fibrosis relative to vessel size in vessels from 
right ventricle (RV, b) and from left ventricle (LV, c). Data are expressed as a percentage.
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Intermittent hypoxia in OSA is associated with increased levels of ROS and elevated production of soluble 
adhesion molecules and pro-inflammatory cytokines29, and is thought to be one of the main components linking 
OSA to cardiovascular disease and atherosclerosis30.
Our results showed enhanced aortic superoxide anion generation, one of the most important ROS species 
within the vasculature, in OSA rats compared to Sham rats. The NADPH oxidase is a major source of ROS31. We 
observed an increase of the aortic protein levels of NADPH oxidase subunit p47phox in OSA rats, in agreement 
with an elevated superoxide production. Our data is consistent with the increased levels of oxidative stress mark-
ers32,33, lipid peroxidation, protein carbonylation and DNA oxidation and an impaired antioxidant capacity in 
OSA patients34.
Our data showed decreased aortic eNOS protein levels and no changes in iNOS mRNA levels in OSA com-
pared to Sham rats, suggesting a reduced NO bioavailability. These results are in agreement with Jelic et al. who 
reported reduced baseline expression of eNOS and phosphorylated eNOS in endothelial cells harvested from 
patients with OSA compared with control subjects. Consistently, flow-mediated dilation was found to be signifi-
cantly decreased in these patients35.
We showed elevated aortic ACE1 protein levels in OSA rats. Angiotensin II (Ang II), generated by the conver-
sion of Angiotensin I through ACE1, has multiple local and systemic effects that finally lead to vasoconstriction, 
inflammation and smooth muscle cell proliferation, thus contributing to the process of atherosclerosis36. RAS 
activation is a well-known signalling pathway implicated in blood pressure control. It has been proposed that 
OSA could contribute to hypertension, observed in approximately 50% of OSA patients, via RAS activation37,38. 
In an experimental study, 35 days of consecutive recurrent hypoxia (30 s, 7 h/day) promoted 8–13 mmHg increase 
of mean arterial blood pressure in rats, which was blunted with the AT1 receptor blocker losartan39. NADPH 
oxidase is a downstream effector of Ang II40,41, suggesting that the increased ACE1 levels may impinge on the 
NADPH oxidase subunits levels and ROS markers discussed previously. Our findings are also in accordance to 
recent works showing that chronic IH exposures lead to the recruitment of CD36(+)high macrophages to the 
aortic wall promoting atherogenesis42,43.
Taking into consideration that only 30–60% of patients are adherent to continuous positive airway pressure 
therapy44, future new therapeutic approaches in order to prevent vascular damage in OSA patients are required. 
Studies have demonstrated anti-inflammatory properties of MSC by regulation of the proliferation and function 
Figure 4. OSA-induced aortic oxidative stress. Representative fluorescence images of aortic OCT sections 
of Sham and OSA rats (a). Quantification of colocalization index (DHE (R)) of dihidroethidium (DHE, red 
fluorescent signal) and nucleus (DAPI, blue) in frozen aortic sections from Sham (n = 12, white columns) and 
OSA (n = 15, blue columns) (b). Representative immunoblots of the NADPH oxidase subunit p47phox and 
α-actin (c). Column graph of the p47phox (d), relative to α-actin band densities from aorta homogenates of 
Sham (n = 7, white columns) and OSA rats (n = 5, blue columns). Data are expressed as mean ± SEM, *p < 0.05, 
**p < 0.01. A p47phox western blot membrane is shown in Supplementary Figure 2.
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of different immune cell types45,46. In terms of OSA, we observed an early release of MSC into peripheral blood 
in response to recurrent obstructions in rats15. In addition, we found that MSC triggered an anti-inflammatory 
response in the same OSA animal model12,13. Although the available data on the role of MSC is still very scarce, it 
has been suggested that the anti-inflammatory properties of MSC could counterbalance the OSA-induced adverse 
structural remodelling. In this context, after MSC infusion we observed a regression of OSA-induced morpho-
logical aortic changes, superoxide anion production, eNOS and ACE1 protein levels imbalance and a reduction 
of iNOS mRNA levels.
In the present work, similar aortic size was found in OSA rats treated with MSC compared to the Sham group. 
In agreement with our results, in a rat model of abdominal aortic aneurism (AA), an endovascular xenograft of 
bone marrow MSCs (BM-MSCs) decreased AA diameter expansion47. Additionally, in apoE−/− mice admin-
istrations of BM-MSCs attenuated the development of Ang II-induced AA48,49. Furthermore, our data shows 
that MSC infusion was able to counterbalance the disruption of elastic fibers associated with OSA, allowing the 
preservation of the aortic wall structure. Similarly, data from Hashizume et al.49 indicate that implantation of 
MSCs contributes to the attenuation of experimental AA growth through elastin preservation in the aortic wall 
associated with down regulation of metalloproteinases and inflammatory cytokines in vivo.
Therefore, MSC may serve as a future therapeutic strategy for OSA patients. However, further experiments 
are needed to confirm the effects of multiple intravenous administrations of MSC as well as the detailed mech-
anisms by which MSC exert such a therapeutic action, in particular whether MSC conditioned medium or 
MSC-extracted exosomes could play a similarly effective role50,51.
In conclusion, in this clinically relevant model, chronic OSA causes outward hypertrophy of descending 
thoracic aorta and elastin disorganization by a mechanism that may involve increased oxidative stress, ACE1 
up-regulation and eNOS down-regulation. MSC infusion reverses aortic structural changes and attenuates super-
oxide anion production and ACE1 and eNOS changes. Our results provide valuable insights into the biologi-
cal mechanisms that promote vascular damage in OSA and suggest that MSC could counterbalance oxidative 
stress, RAS up regulation and endothelial dysfunction in OSA, thus normalizing OSA-induced structural vascu-
lar remodelling. Further research on the mechanisms underlying OSA-induced aortic remodelling would be of 
interest.
Figure 5. Mechanisms of OSA-induced aortic remodelling. Representative immunoblots of angiotensin 
converting enzyme-1 (ACE1), endothelial oxide nitric synthase (eNOS), and α-actin (a). Mean ± SEM protein 
levels of eNOS (b) and ACE1 (c) relative to α-actin from aorta homogenates of Sham (n = 7, white columns) 
and OSA rats (n = 5, blue columns). A eNOS and ACE1 western blot membranes are shown in Supplementary 
Figure 2. Mean ± SEM mRNA levels of eNOS (d) and iNOS (e) relative to Ppib from aorta homogenates of Sham 
(n = 7, white columns) and OSA rats (n = 6, blue columns). *p < 0.05.
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Methods
experimental sleep apnea model. The experimental protocols were approved by the Animal Research 
Ethics Committee of the University of Barcelona and by the Generalitat de Catalunya with the protocol number 
5628. It also conformed to European Community Directive (2010/63/UE) and Spanish guidelines (RD 53/2013) 
for the use of experimental animals.
A chronic model of OSA previously validated by our group was used9. In the first experiment, thirty 
Sprague-Dawley male rats (250–300 g) were randomized into 2 groups: OSA rats (n = 16) were subjected to 
15-second obstructions (60/hour, 6 hours/day, 21 days) in the custom-made setup, and Sham rats (n = 14) were 
placed in the setup without air obstructions. Rats in both groups were progressively adapted to the experimental 
setting by increasing the time within the custom-made setup at a rate of 1 hour each day, up to 6 hours at the end 
of the first week.
Mesenchymal stem cells infusion. To evaluate the effect of MSC, a subsequent set of 16 Sprague-Dawley 
male rats (250–300 g) were randomized into 2 groups: 8 rats undergoing the OSA protocol for 21 days were 
infused with MSC (OSA + M). Eight Sham rats receiving saline vehicle (Sham + S) were used as controls in this 
experiment.
MSC from Lewis rat marrow stromal cells were kindly provided by the Tulane Center for Gene Therapy (New 
Orleans, LA, USA). The cells were cultured and 5 × 106 cells were injected the first day of apneas application and 
every 4 days thereafter, as explained in a previous work12.
All rats were carefully inspected daily during the OSA experiment and none showed any signs of stress or 
MSC-injection related side effects.
euthanasia and sample collection. After 21 days, rats were anesthetized with intraperitoneal urethane 
10% (1 g/kg) and sacrificed by exsanguination through carotid artery catheterization. Descending thoracic aorta 
was rapidly immersed in OCT and frozen for histological measurements and RNA extraction or snap-frozen in 
liquid nitrogen for western blot analyses.
Morphologic analysis of aorta. Haematoxylin-eosin staining was performed in 4-µm frozen OCT-sections 
of descending thoracic aorta. Microphotographs of full aorta sections were obtained (4X) with an Olympus 
BX41TF light microscopy, a DP73 camera (Olympus Corporation, Japan) and image analyser Olympus cellSens 
Standard 1.16 (Olympus Corporation). All the histological measurements were quantified with the ImageJ soft-
ware (NIH, Maryland, USA)52 by an investigator blinded to group assignment.
The internal perimeter (lumen) and external perimeter (external elastic membrane) of the vessel were manu-
ally drawn and their length measured. It was assumed that cross-sectional area was circular in in vivo conditions 
and that both perimeter values corresponded to external and internal circumference length (C). The internal (Di) 
Figure 6. Mesenchymal stem cells infusion normalizes OSA-induced morphological vascular remodelling. 
Representative haematoxylin-eosin stained aortic sections from Sham rats injected with saline vehicle 
(Sham + S) and OSA rats injected with mesenchymal stem cells (OSA + M) (a). Aortic wall thickness (µm, b), 
lumen diameter (mm, c), percentage of wall to lumen ratio (% WT/L, d) from sham rats injected with saline 
vehicle (Sham + S, n = 6, white columns) and from OSA rats injected with mesenchymal stem cells (OSA + M, 
n = 5, blue columns). Representative elastin autofluorescence images from aorta wall from Sham + S and 
OSA + M rats (e). Number of fiber ruptures indexed for area (mm2) in Sham + S (n = 8, white columns) and 
OSA + M (n = 7, blue columns) groups (f). Number of elastic fibers relative to each aorta section in the same 
samples as in F (g).
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and external diameters (De) were determined from the equation D = C/π. Aorta wall thickness (WT) was then 
calculated as WT = (De − Di)/2. The WT to lumen ratio (WT/L, in %) was calculated to estimate wall thickness 
relative to lumen.
Elastic fiber number and disruption. Frozen aortic OCT-sections (10 μm-thick) were used to analyse 
elastic laminae by means of its auto fluorescence, as described in de Thomaz53. Briefly, a set of 3–4 images (40X) 
of elastin green auto fluorescence (excitation 351–364 nm and emission 400–500 nm) were used to assess aortic 
elastic fiber architecture, both in the form of discontinuities and number of fibers. Discontinuity was defined as a 
complete rupture of an elastic fiber, with boundaries at both sides clearly visible. Number of discontinuities were 
quantified and indexed for area (mm2). Elastic fiber number relative to each aorta section area was also quantified.
Aorta RnA isolation and real time pcR analysis. The remaining of the frozen aortic OCT-sections 
were incubated with 0.5 mL of Trizol until the OCT was dissolved. The tissue was then transferred to a new tube 
with 0.5 mL of Trizol to proceed with tissue disruption followed with silica column purification with the mirVana 
miRNA Isolation Kit protocol (Invitrogen). Total RNA (0.15 μg) was retrotranscripted with the High-Capacity 
cDNA Reverse Transcription Kit (Thermo Fisher). eNOS and iNOS mRNA levels were measured with Real time 
PCR with the enzyme SYBR Select Master Mix (4472908, Thermo Fisher). Real time PCR results were normalized 
to the cyclophilin B (Ppib) housekeeping gene, and presented with the 2−ΔΔCt method. Real time PCR details are 
listed in Table 1 below.
Aorta protein isolation and western blot analysis. Frozen aortas were submerged in 0.5 mL of 
ice-cold RIPA Lysis buffer (89901, Thermo-Fisher Scientific, MA, USA) and Halt Protease Inhibitor (1862209, 
Thermo-Fisher Scientific), and homogenized with an Omni TH homogenizer (Omni International Inc.). After 
1 hour of rotation at 4 °C, samples were centrifuged at 10.000 g at 4 °C for 30 minutes. The upper phase was col-
lected and the total protein concentration was quantified with the PierceTM BCA protein Assay method (23227, 
Thermo-Fisher Scientific, MA, USA) relative to a BSA standard curve. Equal amounts of protein (25 μg) from 
Figure 7. Mesenchymal stem cells infusion normalizes mechanisms of OSA-induced vascular remodelling. 
Quantification of the colocalization index of dihidroethidium and nucleus (DHE [R]) in OCT aortic frozen 
sections in Sham rats infused with saline vehicle (n = 7, Sham + S) and OSA rats injected with mesenchymal 
stem cells (n = 8, OSA + M) (a). Mean ± SEM protein levels of eNOS (b) and of ACE1 relative to α-actin in 
Sham + S (n = 8) and OSA + M (n = 8) rats (c). Mean ± SEM mRNA levels of eNOS (d) and iNOS (e) relative 
to Ppib from aorta homogenates of Sham + S (n = 8, white columns) and OSA + M rats (n = 6, blue columns). 
**p < 0.01.
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each aorta were resolved by standard Novex gels methodology (Thermo-Fisher Scientific, MA, USA) as described 
in Ramos et al.12.
To analyse protein levels, the following primary antibodies were used: rabbit polyclonal anti-Angiotensin 
Converting Enzyme 1 (ACE-1, F949) (BS3485, Bioworld Technology, MN, USA), mouse anti-eNOS/NOS Type 
III (610297, BD Biosciences) and rabbit polyclonal anti-p47-phox (H-195) (sc-14015, Santa Cruz Biotechnology 
Inc.). Protein loading normalization was performed against α-actin housekeeping protein using the mouse mon-
oclonal antibody anti-Smooth muscle actin (clone 1A4) (M0851, Dako Diagnostics SA., Denmark). Molecular 
weight of the measured bands is shown in a separate set of rats in Supplementary Figure 1.
Aortic fibrosis quantification. Four micron-thick aortic OCT-sections were stained with Picrosirius-red 
to determine collagen deposition. Four random pictures (40X) from each aortic section were obtained and the 
collagen fraction of the tunica media was assessed with a semiautomatic colour-threshold detection method. 
Collagen content was calculated as a percentage of the total area. Adventitial fibrosis was excluded from the 
analysis.
The same sections were analysed under polarized light with a Leica DMRB microscope, Leica DFC450 camera 
and the Leica software LAS V4.3 in the Confocal Microscopy Core facility (Universitat de Barcelona). Four to five 
random pictures (20X) from each aorta were obtained and collagen I was quantified with the hue definition 0–10 
and 233–255 that identifies red staining. Collagen III was quantified with the hue definition 15–138 that identifies 
green staining. The colour definitions were adapted to our images as described previously54. All collagen quanti-
fications were performed blinded to group assignment, using Image J software for Windows52.
Superoxide detection in aortic sections. The oxidative fluorescent dye dihydroethidium (DHE) was 
used to evaluate in situ production of superoxide anion in frozen unfixed aortic OCT-sections (10 μm-thick). 
Briefly, sections were equilibrated for 30 min at 37 °C in a HEPES buffer solution (pH 7.4) and incubated for 
30 min in a light-protected and humidified chamber at 37 °C with 5-μM DHE solution (D7008, Sigma-Aldrich). 
After DHE was washed, coverslips were mounted using ProLong Gold antifade reagent with DAPI (P36931, 
Thermo-Fisher Scientific). Images were recorded at different excitation wavelengths using the same settings in 
all samples: 350 nm (blue for DAPI) and 590 nm (red for 2-hydroxyethidium). In order to measure the amount 
of colocalization between the two dyes, Pearson’s correlation coefficient (R) was calculated using ImageJ 1.48 v 
software (colocalization analysis plugin) in four areas per each aortic ring.
Morphologic analysis of intramyocardial arteries. Mid-ventricular 4-µm sections were stained with 
Picrosirius-red. Random pictures of left ventricle (LV) and right ventricle (RV) were taken from each sample 
(10X). For each sample, 2 to 4 intramyocardial coronary arteries were localized in both LV and RV. Three differ-
ent areas were quantified for each vessel: perivascular area (A), limited by outer tunica adventitia; external area 
(Ae), limited by outer tunica media; and internal area (Ai), limited by internal elastic lamina. All measures are 
given as a percentage relative to the vessel area. The percentage of lumen area was quantified as [(Ai/Ae) × 100], 
the percentage of tunica media as [(Ae − Ai)/Ae × 100], and the percentage of perivascular fibrosis as [(A − Ae)/
Ae) × 100)].
Statistical analyses. Data are expressed as mean ± standard error of the mean (SEM) or as percentages (%). 
Data adjustment to normality was checked with a residual Q-Q plot. Comparisons between 2 groups were carried 
out with the non-paired Student’s t-test or the non-parametric U Mann-Whitney test when appropriate. P < 0.05 
was considered to be statistically significant. The statistical analysis was carried out using the Prism 5 software 
(GraphPad Software, San Diego, CA, USA).
Data Availability
The datasets used and/or analysed during the current study are available from the corresponding author on rea-
sonable request.
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